Efficacy of the Expectancy Challenge Alcohol Literacy Curriculum on Reducing College Student Alcohol Use and Harms
Launched by UNIVERSITY OF CENTRAL FLORIDA · Nov 7, 2022
Trial Information
Current as of July 01, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The Expectancy Challenge Alcohol Literacy Curriculum (ECALC) is a 50-minute interactive program, and the only non-experiential expectancy challenge that has been successful in significantly reducing alcohol use and harms among college students. In studies focused on mandated students, fraternity and sorority members, and first year college students, ECALC has produced larger effect sizes than experiential expectancy challenge and all widely used programs. ECALC outcome studies have thus far been limited to four weeks, but the design of ECALC suggests that effects might be sustained for much...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Full-time Fist Year College Student
- • AUDIT-C score = 5 or higher (women), 7 or higher (men).
- • Fluent English speaker
- • Able to consent to participate in research
- Exclusion Criteria:
- • Not a Student enrolled at University of Central Florida
- • Pregnant
- • AUDIT score =15 or higher
About University Of Central Florida
The University of Central Florida (UCF) is a leading research institution dedicated to advancing knowledge and improving health outcomes through innovative clinical trials. With a commitment to excellence in research and education, UCF leverages its diverse expertise and state-of-the-art facilities to conduct cutting-edge studies across various medical disciplines. The university's collaborative approach fosters partnerships with healthcare providers, industry leaders, and community organizations, ensuring that clinical trials are designed to address pressing health challenges while adhering to the highest ethical standards. UCF is dedicated to translating research findings into practical applications that enhance patient care and contribute to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Orlando, Florida, United States
Patients applied
Trial Officials
Michael E Dunn, Ph.D.
Principal Investigator
University of Central Florida
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials